These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35426792)

  • 1. Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel.
    Evans DGR; van Veen EM; Harkness EF; Brentnall AR; Astley SM; Byers H; Woodward ER; Sampson S; Southworth J; Howell SJ; Maxwell AJ; Newman WG; Cuzick J; Howell A
    Genet Med; 2022 Jul; 24(7):1485-1494. PubMed ID: 35426792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density.
    Brentnall AR; van Veen EM; Harkness EF; Rafiq S; Byers H; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
    Int J Cancer; 2020 Apr; 146(8):2122-2129. PubMed ID: 31251818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study.
    Evans DG; Brentnall A; Byers H; Harkness E; Stavrinos P; Howell A; ; Newman WG; Cuzick J
    J Med Genet; 2017 Feb; 54(2):111-113. PubMed ID: 27794048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
    Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
    Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk.
    Vachon CM; Scott CG; Tamimi RM; Thompson DJ; Fasching PA; Stone J; Southey MC; Winham S; Lindström S; Lilyquist J; Giles GG; Milne RL; MacInnis RJ; Baglietto L; Li J; Czene K; Bolla MK; Wang Q; Dennis J; Haeberle L; Eriksson M; Kraft P; Luben R; Wareham N; Olson JE; Norman A; Polley EC; Maskarinec G; Le Marchand L; Haiman CA; Hopper JL; Couch FJ; Easton DF; Hall P; Chatterjee N; Garcia-Closas M
    Breast Cancer Res; 2019 May; 21(1):68. PubMed ID: 31118087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
    van Veen EM; Brentnall AR; Byers H; Harkness EF; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
    JAMA Oncol; 2018 Apr; 4(4):476-482. PubMed ID: 29346471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidence.
    Oblak T; Škerl P; Narang BJ; Blagus R; Krajc M; Novaković S; Žgajnar J
    Breast; 2023 Dec; 72():103590. PubMed ID: 37857130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
    Brentnall AR; Cuzick J; Buist DSM; Bowles EJA
    JAMA Oncol; 2018 Sep; 4(9):e180174. PubMed ID: 29621362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heritability of Mammographic Breast Density, Density Change, Microcalcifications, and Masses.
    Holowko N; Eriksson M; Kuja-Halkola R; Azam S; He W; Hall P; Czene K
    Cancer Res; 2020 Apr; 80(7):1590-1600. PubMed ID: 32241951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Breast Cancer Risk Assessment for
    Gallagher S; Hughes E; Kurian AW; Domchek SM; Garber J; Probst B; Morris B; Tshiaba P; Meek S; Rosenthal E; Roa B; Slavin TP; Wagner S; Weitzel J; Gutin A; Lanchbury JS; Robson M
    JCO Precis Oncol; 2021 Jun; 5():. PubMed ID: 34322652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent.
    Roberts E; van Veen EM; Byers H; Barnett-Griness O; Gronich N; Lejbkowicz F; Pinchev M; Smith MJ; Howell A; Newman WG; Woodward ER; Harkness EF; Brentnall AR; Cuzick J; Rennert G; Howell SJ; Evans DG
    Genet Med; 2023 Sep; 25(9):100846. PubMed ID: 37061873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry.
    Pal Choudhury P; Brook MN; Hurson AN; Lee A; Mulder CV; Coulson P; Schoemaker MJ; Jones ME; Swerdlow AJ; Chatterjee N; Antoniou AC; Garcia-Closas M
    Breast Cancer Res; 2021 Feb; 23(1):22. PubMed ID: 33588869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement.
    Darabi H; Czene K; Zhao W; Liu J; Hall P; Humphreys K
    Breast Cancer Res; 2012 Feb; 14(1):R25. PubMed ID: 22314178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.
    Brentnall AR; Harkness EF; Astley SM; Donnelly LS; Stavrinos P; Sampson S; Fox L; Sergeant JC; Harvie MN; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Howell A; Cuzick J; Evans DG
    Breast Cancer Res; 2015 Dec; 17(1):147. PubMed ID: 26627479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended gene panel testing in lobular breast cancer.
    van Veen EM; Evans DG; Harkness EF; Byers HJ; Ellingford JM; Woodward ER; Bowers NL; Wallace AJ; Howell SJ; Howell A; Lalloo F; Newman WG; Smith MJ
    Fam Cancer; 2022 Apr; 21(2):129-136. PubMed ID: 33763779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion of Endogenous Plasma Dehydroepiandrosterone Sulfate and Mammographic Density in Risk Prediction Models for Breast Cancer.
    Gabrielson M; Ubhayasekera KA; Acharya SR; Franko MA; Eriksson M; Bergquist J; Czene K; Hall P
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):574-581. PubMed ID: 31948996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population.
    Senda N; Kawaguchi-Sakita N; Kawashima M; Inagaki-Kawata Y; Yoshida K; Takada M; Kataoka M; Torii M; Nishimura T; Kawaguchi K; Suzuki E; Kataoka Y; Matsumoto Y; Yoshibayashi H; Yamagami K; Tsuyuki S; Takahara S; Yamauchi A; Shinkura N; Kato H; Moriguchi Y; Okamura R; Kan N; Suwa H; Sakata S; Mashima S; Yotsumoto F; Tachibana T; Tanaka M; Togashi K; Haga H; Yamada T; Kosugi S; Inamoto T; Sugimoto M; Ogawa S; Toi M
    Cancer Sci; 2021 Aug; 112(8):3338-3348. PubMed ID: 34036661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
    Evans DG; van Veen EM; Byers H; Roberts E; Howell A; Howell SJ; Harkness EF; Brentnall A; Cuzick J; Newman WG
    Int J Cancer; 2022 Jan; 150(1):73-79. PubMed ID: 34460111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
    Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
    BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.